Our iGEM team, PolYneer, is thrilled to have the opportunity to collaborate with the Hong Kong Cancer Fund (HKCF) as part of their human practices component for their research project on developing a novel bispecific antibody to overcome osimertinib resistance in non-small cell lung carcinoma (NSCLC). The team has designed and launched a T-shirt selling campaign, which raised over 20,000 HKD and was donated to HKCF on January 10, 2024. Because of their outstanding performance in terms of both scientific merit and social contribution, a team from the HKCF visited our department to interview our IGEM team on January 16, 2024. The team’s efforts were recognized as a feature in the biannual Intouch magazine of the HKCF in mid-2024. The department is proud of the team's achievements and looks forward to continuing to collaborate with the HKCF in the future.
